WAT · Earnings call · 2026Q2T · Full report

Guidance / Outlook

WATERS CORP /DE/ · 2026-08-04 · Importance 74 · Surprise 68

Waters raised its 2026 organic constant-currency revenue-growth guidance to 7% to 9%, implying organic reported revenue of $3.37 billion to $3.431 billion after a roughly 60-basis-point FX headwind. Biosciences and Diagnostic Solutions revenue guidance increased by $10 million to approximately $3.045 billion, producing total 2026 reported revenue guidance of approximately $6.415 billion to $6.476 billion. For the third quarter, management expects organic constant-currency growth of 8% to 10%, total reported revenue of $1.745 billion to $1.762 billion, and adjusted EPS of $3.95 to $4.05; acquired businesses are expected to exit 2026 at 6% or better growth.